Champions Oncology Inc

CSBR's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

CSBR Growth rates comparisons

Champions Oncology Inc 's sales fell by -0.47 % in the first quarter of 2025 from the same quarter a year ago. Ranking at No. 2303

Biotechnology & Pharmaceuticals industry recorded growth of revenues by 1.92 %

Champions Oncology Inc faced net loss in contrast to the net income a year ago in first quarter of 2025

• More on CSBR's Growth

CSBR's Valuation comparisons

Champions Oncology Inc
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Champions Oncology Inc PEG ratio is at -0.18 Company is currently trading with Price to Cash flow multiple of 12.61 in trailing twelve-month period.

Company

32.23

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 1.65.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.12.

• More on CSBR's Valuation

Total Debt (Millions $)	-
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	355,488
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	4.84
Tangible Book Value (Per Share $)	0.23

CSBR's Valuation comparisons

Company

32.23

PE TTM

Industry

PE TTM

Company's Price to Sales ratio is at 1.65.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 7.12.

Champions Oncology Inc Price to Book Ratio is at 26.5 lower than Industry Avg. of 2645.5. and higher than S&P 500 Avg. of 0.02

• More on CSBR's Valuation

• Market Capitalization (Millions $)	94
• Shares Outstanding (Millions)	14
• Employees	160
• Revenues (TTM) (Millions $)	57
• Net Income (TTM) (Millions $)	3
• Cash Flow (TTM) (Millions $)	7
• Capital Exp. (TTM) (Millions $)	0
• Total Debt (Millions $)	-
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	355,488
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	4.84
• Tangible Book Value (Per Share $)	0.23

• Market Capitalization (Millions $)	94
• Shares Outstanding (Millions)	14
• Employees	160
• Revenues (TTM) (Millions $)	57
• Net Income (TTM) (Millions $)	3
• Cash Flow (TTM) (Millions $)	7
• Capital Exp. (TTM) (Millions $)	0

	*Ratio*
• Capital Ratio (MRQ)	3.11
• Total Debt to Equity (MRQ)	-
• Tangible Leverage Ratio (MRQ)	2.14
• Asset Turnover Ratio (TTM)	1.92
• Inventory Turnover Ratio (TTM)	-

CSBR's Profitability Comparisons

• More on CSBR's Key Ratios

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.